BioLife Solutions, Inc. (BLFS) Income Statement

The 2024Q4 revenue figure is negative due to the divestiture of the Stirling Ultracold and CBS freezer businesses, which distorts the historical trend. Excluding that anomaly, revenue has shown sequential improvement from $18.4M in 2024Q1 to $28.5M in 2026Q2, indicating a recovery in the core consumables business. However, the growth rate has decelerated from the 29.9% seen in 2025Q1 to 12.0% in 2026Q2, suggesting a maturing base or potential market saturation. Investors should monitor whether this deceleration is a temporary effect of the divestiture or a sign of slowing demand in the CGT sector.

The gross margin of 64.2% in 2026Q2 is consistent with the company's historical range, indicating that the core media products maintain their pricing power. However, the operating margin improvement from -65.5% to 6.0% is largely attributable to a reduction in SG&A expenses and a one-time gain, as evidenced by the $45.1M net income on $1.7M operating income. This suggests that the underlying operations are still not generating sustainable operating profits, and the margin expansion may not be durable. The company's gross margin is significantly higher than peers like Azenta (45.5%) and Cryoport (47.1%), reflecting its proprietary media's value, but the high fixed costs continue to pressure the bottom line.

The company's cost structure is heavily weighted toward SG&A, which has remained in the $12-15M range even as revenue fluctuates. This suggests that the business has not yet achieved the scale needed to spread fixed costs effectively. The 2026Q2 operating margin of 6.0% is a significant improvement from the -65.5% in 2025Q2, but that quarter included a large impairment charge. Excluding one-time items, the operating margin appears to be in the low single digits, indicating that the company is still in an investment phase. Investors should watch for SG&A discipline as a key indicator of future operating leverage.

The cost structure reveals that SG&A is the dominant expense line, representing about 47% of revenue in 2026Q2, while R&D is only about 10%. This allocation indicates that the company is investing heavily in sales and marketing to drive adoption of its media products, but it also means that operating profitability is highly sensitive to revenue growth. The divestiture of the freezer business should reduce some SG&A overhead, but the remaining cost base may still be too high for the current revenue scale. Management's expense discipline will be critical to achieving sustained profitability, as the gross margin alone cannot offset the fixed cost burden.

The 2025Q2 results show a dramatic deterioration in profitability, with operating margin at -65.5%, which is likely due to one-time charges associated with the divestiture of the Stirling Ultracold business. This quarter appears to be the turning point where management decided to exit the capital-intensive equipment segment and refocus on high-margin consumables. The subsequent quarters show a gradual recovery in operating income, culminating in the positive 6.0% margin in 2026Q2. This inflection suggests that the company is emerging from a period of restructuring, but the sustainability of the recovery depends on the successful execution of the consumables-first strategy.